I
n Europe, HIV and other sexually transmitted diseases (STD) remain of major public health importance. 1 Ongoing transmission of many STDs is reflected in persistently high positivity rates, posing serious risks for individuals and for public health. In industrialized countries like the Netherlands, surveillance data show yearly high numbers of new STD diagnoses, despite extensive efforts to control STDs by targeted prevention, rapid diagnosis, and treatment services. 2, 3 In the Netherlands, STD testing and treatment is provided by general practitioners (GPs) and STD clinics. In 2007, about 70% of STD related episodes were seen at GPs and 30% at STD clinics (van den Broek IV, et al, unpublished data, 2009). The latter offering additional first line care targeted at high risk populations.
Since STD transmission is uniquely linked to human behavior, its control depends on the identification of important risk groups and their risk behaviors associated with STD transmission. Anyone diagnosed with an STD has been at increased risk for any other STD as well, and simultaneous infection with more than one STD is common. 4, 5 Nevertheless, little recent data have been published on the extent of STD coinfections in high-risk populations, with the exception of STD in HIVinfected patients 5, 6 and interactions between HSV-2 and HIV infections. 7, 8 We hypothesize that populations coinfected with STD may have a high transmission potential and therefore need to be identified.
In this study, we set out to determine the extent of concurrent incident bacterial STD infections and their risk factors by using a unique dataset that included data about all STD clinics in the Netherlands. Our goal was to identify specific subpopulations, at risk for STD coinfections, who may facilitate several STD transmission chains. These specific populations may have extremely high risk behavior in overlapping sexual networks and therefore would need to be targeted with intensified future interventions to curb this ongoing STD epidemic.
MATERIALS AND METHODS
In the Netherlands, 32 STD clinics, distributed across eight regions, offer STD testing and treatment. This includes HIV testing, free of charge, targeted at high-risk groups, and people who want to be tested anonymously. Each region has one STD centre that is responsible for regional coordination of STD control. All new STD consultations and corresponding diagnoses are rendered anonymous and reported to the Centre for Infectious Disease Control (RIVM) for surveillance purposes. The reporting of STD consultations is facilitated by a web based application (SOAP) that is nationwide since 2004.
Study Population
From January 2004 to December 2007, 268,071 new STD consultations were registered in the national database at the RIVM. A new STD consultation was defined as a consultation for new symptoms or one resulting from routine STD screening of asymptomatic cases, both involving laboratory testing and medical examination. Data does not allow identification of repeat visits in the same individual. However, only consultations for a new STD episode are included and follow-up visits in the same individual, e.g., for treatment genital warts, are not included in the data. Additionally for this study, data were excluded from STD consultations with known HIV-positive STD clinic attendees (n � 3134) since their awareness of HIV positivity gives them a distinct risk profile. Concurrent STD in HIV-positive clinic attendees will be analyzed and described elsewhere (report in preparation).
Procedures
At each consultation, information on demographics (gender, year of birth, ethnicity), behavior (sexual preference, STD history, commercial sex contacts, injecting drugs), diagnostics and clinical outcome is recorded by the clinician or nurse in the online RIVM registration database. All clinic attendees are offered testing for chlamydia, gonorrhea, and syphilis. Hepatitis B and HIV testing are optional, however, HIV testing is actively offered and had increased to 85% in 2007. 2 Testing for other STDs, such as trichomonas, HSV, and genital warts was performed on clinical indication. Microbiologic diagnostics were carried out locally at laboratories related to the STD centers in accordance with standard procedures established in a STD screening protocol, 9 including quality control measures. All laboratories used nucleic acid amplified tests (NAAT) in urine or urethral specimens to diagnose Chlamydia. The method used to diagnose gonorrhea varied among regions. Some regions used culture tests for Neisseria gonorrhea (NG) diagnosis in clinic attendees who presented with complaints, whereas they used NAAT as a screening test for NG for individuals without complaints. Other regions used NAAT to test for NG for all clinic attendees, regardless of complaints. Syphilis testing is done using Treponema pallidum particle agglutination assay (TPPA). According to the STD screening protocol, enzyme immunoassays (EIAs) may be used as an alternative test to diagnose syphilis. Fluorescent treponemal antibody absorption (FTA-ABS) test is recommended for confirmation. 9 An STD coinfection was defined as diagnosis of two or more incident bacterial STDs. We included only the STDs that are routinely screened for at each consultation (chlamydia, gonorrhea, and infectious syphilis). Additionally, we conducted a second analysis that included all diagnoses, including newly detected HIV infections, acute hepatitis B infections and those tested for on clinical indication (genital warts and genital herpes in both sexes, and trichomonas in women).
Statistical Analyses
We used logistic regression analyses to study associations of patient characteristics and individual behavior in cases of incident bacterial STD coinfections among clinic attendees. First, we studied associations with (a) STD mono diagnosis (chlamydia, gonorrhea, or infectious syphilis), and (b) STD coinfections (chlamydia, gonorrhea, and/or infectious syphilis), comparing these 2 groups with STD clinic attendees having no infection. We then tested for potential interactions between the identified risk factors, and stratified our further analyses by sexual preference, as heterosexual attendees and MSM attendees had different risk profiles. A multivariate model was built by selecting variables that were statistically significant (P � 0.05) in univariate analysis. Finally, we repeated our analyses, using all STD diagnoses including newly detected HIV infections, acute hepatitis B infections and STD found by testing after clinical indication (genital warts, genital herpes, and trichomonas in women). Analyses were carried out using the SAS software 9.1.3 (SAS Institute, Inc., Cary, NC).
RESULTS
Over 4 recent years, the annual number of new STD consultations in the Netherlands increased by 34%, rising steadily from 58,288 in 2004 to 78,062 in 2007 (P � 0.0001). Women accounted for 49% of consultations, heterosexual men for 37%, MSM for 13%, and transgendered persons for 0.04% of all consultations ( Table 1 ). The majority of clinic attendees were Dutch (78%), 4% were of other European origin, 6% were from Surinam or the Netherlands Antilles, 2% were Turkish or Moroccan, 2% were from Sub Saharan Africa, and 8% were from other countries. Of the total, 40% were younger than 25 years of age.
Overall, a bacterial STD was diagnosed in 12% of STD visits. Concurrent STD infections including coinfections of chlamydia, gonorrhea, and infectious syphilis were diagnosed in 2120 (7%) of all 31,754 incident bacterial STD diagnoses (Table 1) . Of the STD coinfections, 83% were concurrent chlamydia and gonorrhea infections ( Table 2) . About half (44%) of the STD coinfections were diagnosed in MSM, although MSM accounted for 13% of consultations and 20% of mono diagnoses. Of the ethnic groups, the Surinamese/Antillean group had the most STD coinfections (19%), with 10% of mono diagnoses and 6% of consultations. If we included all STD diagnoses, including newly detected HIV infections, acute hepatitis B infections and STD diagnosed on clinical indication (genital warts, genital herpes, and trichomonas in women), we calculated 3766 STD coinfections.
Associations for STD Coinfections
Logistic regression analyses among all STD clinic attendees who were HIV-negative or not aware of their HIV status showed that MSM were at higher risk for STD coinfections than heterosexuals (unadjusted OR � 5.4; 95% CI: 4.9 -5.9). The youngest age group (below 19 years) was at higher risk for STD coinfections compared to older age groups. However, we found significant interaction between sexual preference and age (P � 0.001) and therefore stratified our analyses by sexual preference in a multivariate analysis. When analyses were repeated for associations with coinfections, including newly detected HIV infections, acute hepatitis B infections and STD found on testing after clinical indication, similar associations were found in all groups (data not shown).
Associations for STD Coinfections, Stratified by Sexual Preference
An analysis stratified by sexual preference, yielded an age distribution that differed between MSM and heterosexuals. As shown in Figure 1A , MSM showed an increasing linear age trend (P � 0.0001 � 2 trend) in coinfections, monodiagnoses, and consultations. In heterosexuals, how- ever, Figure 1B shows that diagnoses and consultations were decreasing with age (P � 0.0001 � 2 trend). Heterosexuals aged 19 years or younger accounted for 27% of all coinfections, while having only 14% of monodiagnoses and 10% of consultations. These different associations by age groups for MSM and heterosexuals were confirmed in multivariate logistic regression analyses when it was stratified by sexual preference (Tables 3, 4 ). In heterosexuals, the highest risk was in the young (19 years of age or younger, OR � 6.8) and afterwards declined; in MSM, the older age groups (25-39 years of age) were at highest risk.
Stratified by sexual preference, STD clinic attendees of Surinamese/Antillean origin were found at increased risk for coinfections, in both sexual strata. However, this association was stronger in heterosexual attendees (OR � 6.5) than in MSM attendees of Surinamese/Antillean origin (OR � 1.5).
No clear trend in time was observed for associations with STD coinfections. The associations of ethnicity, age, gender, and sexual preference with STD coinfections were much stronger than the associations of these factors with STD mono diagnoses. Again, stratified analyses of coinfections, including diagnoses of new HIV-infections, acute hepatitis B infections, genital warts, genital herpes, and trichomonas in women, showed comparable associations (data not shown).
DISCUSSION
Bacterial STD coinfections were diagnosed in 7% of all incident STD diagnoses. The majority were coexisting chlamydia and gonorrhea infections. MSM were at highest risk for STD coinfections, in particular MSM aged 25 to 39 years. In heterosexuals, those 19 years of age or younger were at highest risk. Independent of sexual preference, clinic attendees of Surinamese/Antillean origin were more often diagnosed with multiple bacterial STD compared to other ethnic groups.
MSM are widely recognized as a core group in STD acquisition and transmission. Many studies have reported on STD infections in MSM, and some focus on STD coinfections in HIV-positive MSM. 5, 10 A recent WHO publication observed that the incidence of HIV in older individuals is surprisingly high and the risk factors are as yet unexplored. 11 We found in this study that coinfections are common among MSM who are HIV-negative or not aware of their HIV status when they visit the clinic. In the Netherlands, STD and HIV prevention is targeted at specific high-risk groups, including MSM. Continuous efforts must be made in primary prevention, as well as in secondary prevention, by actively offering full STD screening to MSM. Additionally, it is advisable to explore the role of general practitioners (GPs) in opportunistic screening for STD (co)infections. Since coinfections are more common in MSM clinic attendees than non-MSM clinic attendees, MSM should be tested for all prevalent STI, in particular when they are older. Regardless of sexual preference, young people are vulnerable for STD acquisition and transmission for a combination of reasons involving biology, psychology, ambient culture, and changing mores. 12 In general, when rates are corrected for those who are sexually active, the youngest adolescents have the highest STD rates of any age group. Some immunity may develop following an initial or serial infection with a specific STD. On the other hand, emergence of protective immunity induced by chlamydial infection is not well understood. 13 Young people are another STD risk group that is targeted specifically by prevention organizations in the Netherlands. For example in 2008, a chlamydia screening initiative has started in 3 geographical regions in the country, targeted at young people aged 16 to 29 years. 14 Our study shows that screening of young people diagnosed with chlamydia at STD clinics should include testing for other bacterial STD as well, particularly those aged 19 years or younger. This is confirmed by an English study on coinfections found in opportunistic chlamydia screening. Of the women screened at GUM clinics, 28% had a coexisting STD. 15 Before our study, community-based research in the 
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Netherlands on chlamydia prevalence and coexisting gonorrhea showed a very low prevalence of coinfections. Nevertheless, the authors advised that all persons positive for chlamydia should also be tested for gonorrhea. 16 Our study may be the first to report on STD coinfections specifically among ethnic groups. However, associations between African and Caribbean ethnicity and infections with bacterial STDs have been shown before. 17 In England, people of black ethnic backgrounds are disproportionately affected by STDs. 18 In the Netherlands, ethnic groups from Surinamese and the Netherlands Antilles account for 26% of the non-Western migrant population living in the Netherlands of whom 50% congregates in one of the four main cities in our country. 19 Positivity rates among STD clinic attendees of Surinamese/Antillean background are higher than among attendees from other ethnic groups. 2 In addition, first results of the chlamydia screening initiative show that Surinamese and Antillean migrants were less likely than Dutch natives to participate in the screening program whereas they were more likely to be tested positive for chlamydia (Op de Coul EL et al, unpublished data, 2009). Such differences in positivity rates might be due to sexual mixing patterns within ethnic groups. 20 Because cultural values are shared within ethnic groups, individuals are more likely to have relationships with members of their own group than with others. The majority (59%) of Surinamese and Antillean migrants in the Netherlands reported partners of their own ethnic group. 21 This assortative mixing fuels the spread of STD within subpopulations 22, 23 and thus may lead to higher positivity ratios and a higher chance of acquiring multiple STD within those groups. In addition, we see higher rates of concurrent sexual partners among Surinamese and Antillean migrants, compared to the general population. 24 Moreover, STD clinic attendees of Surinamese/Antillean origin are often young and might be more vulnerable for multiple infections because of their age and corresponding behaviors. Since 2006, HIV and STD primary prevention in the Netherlands is culturally tailored to reach specific ethnic groups. These results show that despite tailored prevention measures, more efforts should be made to reach these groups. Other prevention measures such as secondary prevention (STD testing and partner notification) should become more easily available for ethnic minority populations. In addition, further studies are needed to disentangle (biologic) risk factors for STD acquisition in different ethnic groups.
Our study had several limitations. First, the results from a study among STD clinic attendees should be extrapolated to the wider population with caution. Although clinic consultations increase each year, most people in the Netherlands consult their GP for STD testing. 16 GPs should therefore be alert of the risk of STD coinfections, and multiple testing is indicated in specific risk groups, such as young people diagnosed with chlamydia, MSM, and ethnic groups from Surinam/Antilles. On the other hand, a comparative study of data from STD clinics and GP surveillance shows that STD clinics attract relatively more high-risk persons than GPs, and that chlamydia, gonorrhea, and syph- ). Second, we could not differentiate recidivism in our study since a unique personal identifier was lacking in our data. Some individuals may have had more than one STD consultation for a new STD episode; therefore risk factors cannot be totally attributable to individual reports. Furthermore, our results show that coinfections are more prevalent in networks like young heterosexuals, specific ethnic groups and older MSM suggesting heterogeneity of risk behavior within these populations or bridging of these sexual networks. However, because of the nature of our data we could not conduct network analyses. Further research on sexual networks is needed to elucidate the contribution of coinfected individuals to the spread of STD.
In conclusion, this study shows that specific sexual networks such as MSM, ethnic groups, and young heterosexuals are at highest risk for bacterial STD coinfections. The different age-related trend in MSM versus heterosexuals suggests that these high-risk networks may have different determinants that put members at higher risk, such as agerelated sexual risk-taking, biologic susceptibility, and insufficient knowledge or compliance with prevention measures. Despite screening and treatment efforts, these sexual networks may disproportionately fuel the ongoing STD epidemic. Prevention and treatment efforts involving general practitioners and STD clinics, combined with research to unravel transmission drivers and to improve interventions, should therefore be targeted differently towards these specific high-risk sexual networks, in particular those networks identified with concurrent STDs.
